Construction and verification of Chinese medicine syndrome differentiation diagnostic criteria for early breast cancer
- Conditions
- Breast cancer
- Registration Number
- ITMCTR2200006139
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
(1)Patients whose pathology meets the diagnostic criteria of early breast cancer (stage I-III, excluding distant metastasis);
(2)Female patients over 18 years old (including 18 years old);
(3)Patients with a score of 0-2 in ECOG (Eastern Cooperative Oncology Group);
(4)Patients who voluntarily participated in the study and signed informed consent.
(1)Serious accompanying diseases such as cardio-cerebrovascular or psychological disease;
(2)Receiving the neoadjuvant, or receiving the chemotherapy, radiotherapy, or endocrine treatment simultaneously;
(3)Complications of breast cancer treatment, such as postoperative wound infection, severe lymphoedema, neutropenic fever or radiation pneumonia;
(4) Pregnant or breastfeeding participants.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Signs and symptoms, Chinese medicine syndromes and Chinese herbal formulas.;
- Secondary Outcome Measures
Name Time Method